Latest News
DeepMatter Share Price Jumps On Merck Licencing Deal and Raised Revenue Guidance
Key points: DeepMatter announces licencing agreement with Merck The company now expects revenue for the year to be 50% above 2021 DeepMatter shares surged 67% Wednesday
USDJPY Price Analysis: Yen Remains Weak on BoJ Policy Stance
Key points: The USDJPY pair was trading sideway amid the US dollar weakness. The pair will keep rising until the BoJ abandons its easy money polici
Chargepoint (CHPT) and EV Charging Stocks Tumble on Concerns
Key points: ChargePoint and EV charging stocks tumble of Buy American concerns. Analysts have singled out the DoT for skirting the government manda
JetBlue Stock Falls Despite Reporting a Quarterly Profit
Key points: JetBlue reported earnings on Tuesday The company posted a quarterly profit JBLU shares are down over 4% premarket
3M Stock Declines After Cutting Full-Year Forecasts
Key points: 3M reported Q3 earnings before the open on Tuesday The company cut guidance MMM shares are down over 2% 3M (NYSE: MMM) shares are down o
Analysts Cut Meta Platforms Stock Price Targets Ahead of Q3 Earnings
Key points: Meta Platforms price target has been cut at Mizuho and KeyBanc On Monday, Morgan Stanley downgraded the stock Meta will report
Why Mullen (MULN) Stock Rallied 18%, Extending Monday’s Rally
Key points: The Mullen Automotive stock price rallied 18%, extending yesterday’s rally. Investors cheered the firm securing the I-Go branding and s
Cineworld Share Price: Can Blockbuster Movies Save Cineworld?
Key points: Cineworld shares are trading down 92.8% YTD. So can blockbuster movies push their shares higher? Read on to
Tesla Discloses $170 million Bitcoin Losses
Key points: Tesla Reports $170 Million Impairment Loss on Bitcoin Investment Bitcoin Holding, Accounting Rules and Impairment Loss The E-Car Company Comments on Crypto
Premier Inn Owner Whitbread Swings To First Half Profit
Key points: Whitbread released interim results on Tuesday The company reported a H1 pre-tax profit However, WTB warned of rising costs
THG Shares Jump After Maintaining Outlook
Key points: THG said Q3 revenue growth was 2.1% The company announced the signing of a new banking facility THG shares jumped 20% Tuesday Shares of
Here’s Why KEFI Shares Barely Moved on the Q3 Progress Update
Key points: KEFI shares edged higher on releasing its Q3 operations update. The company expects to commission its two lead projects in 2024.
Empire Metals’ Share Price Surged 35.6% on the Pitfield Update
Key points: Empire Metals’ share price surged 35.6% on the Pitfield project update. The firm noted that Pitfield could have a giant copper mineralisa
Power Metal Resources Shares Rise After Identifying Electromagnetic ‘Superconductor’ at Molopo Farms Complex Project
Key points: Power Metal Resources issued an update for its Molopo Farms Complex Project A geophysical EM superconductor has been identified POW shares gained over 3% Tues
GBPUSD Price: Pound Sidelined As Investors Await Sunak Speech
Key points: The pound rose, then fell after Rishi Sunak won the leadership contest. The new Prime Minister must unite his party and restore public
Tesla Stock Slides After Cutting Model 3 and Model Y Prices In China
Key points: Tesla cut starter prices for its Model 3 and Model Y according to Reuters The price cuts were up to 9% Tesla shares fell Monday
Tricida Stock Crashed 94%, Trial Failed To Meet Primary Endpoints
Key points: Tradicida stock crashed 93.8% after a clinical trial failed to meet primary endpoints. Patients taking the veverimer CKD drug performed
Philips Earnings Impacted By Supply Challenges – Announces Job Cuts
Key points: Philips reported Q3 results Monday The company said it faces operational and supply challenges Philips announced it will cut around 4,000 jobs globally
Applied Genetic Tech (AGTC) Stock Soared 65% on Takeover Deal
Key points: Applied Genetic Tech (AGTC) stock soared 64.7% on the takeover deal. A subsidiary of Syncona Limited will acquire the company for $23.5
Vaxcyte Stock Surges On Positive VAX-24 Phase 1/2 Trial Data
Key points: Vaxcyte announced VAX-24 met primary safety and tolerability objectives VAX-24 demonstrated a safety profile similar to Pfizer's Prevnar 20 Vaxcyte shares surg